2,5-Dioxopyrrolidin-1-yl 1-azido-9-(2-(2-(2-azidoethoxy)ethoxy)ethyl)-10-oxo-3,6,13,16-tetraoxa-9-azanonadecan-19-oate

Catalog No. :
ACCPWR610
CAS No. :
2751373-29-0
Molecular Formula :
C24H40N8O11
Molecular Weight :
616.63

IUPAC Name:2,5-dioxopyrrolidin-1-yl 1-azido-9-(2-(2-(2-azidoethoxy)ethoxy)ethyl)-10-oxo-3,6,13,16-tetraoxa-9-azanonadecan-19-oate

2,5-Dioxopyrrolidin-1-yl 1-azido-9-(2-(2-(2-azidoethoxy)ethoxy)ethyl)-10-oxo-3,6,13,16-tetraoxa-9-azanonadecan-19-oate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,5-Dioxopyrrolidin-1-yl 1-azido-9-(2-(2-(2-azidoethoxy)ethoxy)ethyl)-10-oxo-3,6,13,16-tetraoxa-9-azanonadecan-19-oate
IUPAC Name2,5-dioxopyrrolidin-1-yl 1-azido-9-(2-(2-(2-azidoethoxy)ethoxy)ethyl)-10-oxo-3,6,13,16-tetraoxa-9-azanonadecan-19-oate
Molecular FormulaC24H40N8O11
Molecular Weight616.63
SMILESO=C(N1OC(CCOCCOCCC(N(CCOCCOCCN=[N+]=[N-])CCOCCOCCN=[N+]=[N-])=O)=O)CCC1=O
InChI KeyQDRGBDBSDHGRIY-UHFFFAOYSA-N
SynonymBis(N3-PEG2-CH2CH2)-N-CO-PEG2-CH2CH2COONHS;Propanoic acid, 3-[[15-azido-7-[2-[2-(2-azidoethoxy)ethoxy]ethyl]-6-oxo-3,10,13-trioxa-7-azapentadec-1-yl]oxy]-, 2,5-dioxo-1-pyrrolidinyl ester
CAS No.2751373-29-0

Synthetic Route by SureRoute

1. ACCPWR610 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCPWR610 route product structure diagram
    ACCPWR6102751373-29-0
Inquiry

2. ACCPWR610 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCPWR610 route product structure diagram
    ACCPWR6102751373-29-0
Inquiry

Comments (0)